Annalee Armstrong - Profile and Journalist Details
Find journalists that align with your industry, location and vision. Unlock Annalee Armstrong's full journalist profile, including location, coverage topics, current employer, biography and preferences. Sign up today and start building journalist relationships that fuel your startup's growth.
Get connected with journalists today
Annalee Armstrong
Verified
Senior Editor, BioSpace
Ottawa
Beats
also security as it relates to these.Front end and web development
extreme sports
Content
By Annalee Armstrong Verified| BioSpace Verified Johnson & Johnson CEO Joaquin Duato urged President Donald Trump to consider tax policy changes to encourage more U.S. manufacturing of pharmaceuticals—rather than enacting tariffs that could greatly cut into the company’s profits. “If what you want is to build manufacturing capacity in the U.S., both in medtech and in pharmaceuticals, the most effective answer is not tariffs, but tax policy,” Duato told investors on J&J’s first-quarter earnings call Tuesday morning.
By Annalee Armstrong Verified| BioSpace Verified Johnson & Johnson’s medicines, including Tremfya and Carvykti, helped drive a worldwide sales increase of 2.4% in the first quarter, the company reported Tuesday morning. As always, J&J was the first out the gate for pharma earnings, reporting sales of $21.9 billion and diluted earnings per share of $4.54. The medicines unit provided $13.9 billion while the medtech unit kicked in the remaining $8 billion.
By Annalee Armstrong Verified| BioSpace Verified Johnson & Johnson CEO Joaquin Duato urged President Donald Trump to consider tax policy changes to encourage more U.S. manufacturing of pharmaceuticals—rather than enacting tariffs that could greatly cut into the company’s profits. “If what you want is to build manufacturing capacity in the U.S., both in medtech and in pharmaceuticals, the most effective answer is not tariffs, but tax policy,” Duato told investors on J&J’s first-quarter earnings call Tuesday morning.
Company Info
BioSpace
BioSpace is a prominent digital hub for the life sciences sector, based in Iowa, United States. The company connects innovative organizations with talented professionals by providing essential insights, opportunities, and tools. With a team of 51 to 200 employees, BioSpace focuses on delivering comprehensive news coverage, job listings, and career development resources tailored to the biotech, pharmaceutical, and clinical research fields. The platform features a variety of services, including industry analysis, podcasts, and annual lists of promising new biopharma companies. BioSpace also offers in-depth reports that analyze industry trends and challenges, serving as valuable resources for both investors and professionals. By facilitating connections within the life sciences community, BioSpace plays a vital role in fostering collaboration and driving innovation in the industry.
West Des Moines, Iowa, United States
+1 650-460-3308
Founded: 1985